[Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy].
K R DudinaP A BelyyIgor MaevE A KlimovaS A ShutkoO O ZnoykoN D YuschukPublished in: Terapevticheskii arkhiv (2023)
The high proportion of patients with elevated BMI and liver steatosis seen years after a successful CHC therapy indicates a continued risk of progression of chronic liver disease. Such patients should be advised on how important it is to change their lifestyle to reduce overweight and prevent weight gain. We also need long-term assessments of how liver steatosis changes over time and what are the outcomes associated with post-SVR increase in BMI.
Keyphrases
- weight gain
- body mass index
- birth weight
- weight loss
- physical activity
- insulin resistance
- end stage renal disease
- high fat diet
- newly diagnosed
- ejection fraction
- metabolic syndrome
- cardiovascular disease
- prognostic factors
- high fat diet induced
- peritoneal dialysis
- adipose tissue
- bone marrow
- replacement therapy
- preterm birth
- smoking cessation
- clinical evaluation